Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8564279 | PMC |
| http://dx.doi.org/10.1057/s41301-021-00316-x | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Biliary sphincterotomy resets pancreaticobiliary pain refractory to intrasphincteric Botox injections in functional biliary pain.
Indian J Gastroenterol
December 2024
Department of Gastroenterology, The Royal Wolverhampton NHS Trust, New Cross Hospital, Wednesfield Road, Wolverhampton, WV10 0QP, UK.
Background: The management of Type III sphincter of Oddi dysfunction or functional biliary pain (FBP) is challenging. A strategy of intermittent intrasphincteric botulinum toxin (Botox) injections into the sphincter of Oddi can alleviate pancreaticobiliary pain. In patients who lose response to intermittent Botox injections, endoscopic biliary sphincterotomy (ES) could potentially reset pain facilitating ongoing management of symptoms.
View Article and Find Full Text PDFPractical considerations in the establishment of psychedelic research programs.
Psychopharmacology (Berl)
January 2025
Department of Pharmacology, Toxicology and Neuroscience, Louisiana State University Health Sciences Center, Shreveport, LA, 71130, USA.
Rationale: There is increasing interest in establishing psychedelic research programs at academic medical centers. However, psychedelics are intensely psychoactive, carry considerable sociopolitical baggage, and most are Schedule I drugs, creating significant potential impediments to implementation. There is little formal guidance for investigators on navigating the complex on-the-ground obstacles associated with establishing psychedelic research programs.
View Article and Find Full Text PDFEditorial to "Atypical atrial resetting with ventricular extrastimulus during tachycardia: What is the mechanism?".
J Arrhythm
October 2024
Division of Cardiovascular Medicine Saitama Medical Center, Jichi Medical University Saitama Japan.
Editorial: Neuromodulation using spatiotemporally complex patterns.
Front Neuroinform
August 2024
Boston Scientific Neuromodulation, Valencia, CA, United States.
The SafeBoosC-III trial and the future of cerebral oximetry-guided interventions in preterm infants-time to pause and reset?
Transl Pediatr
June 2024
Division of Neonatology, Children's Mercy Hospital, Kansas City, MO, USA.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!